What is TTRX's accrued liabilities & other?

TTRX (TTRX) reported accrued liabilities & other of $2.32M in Q1 2026.

What does accrued liabilities & other mean?

Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.

Tarsus Pharmaceuticals, Inc.TARS

$110.85M+45.1%

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Operating cash flow-$1.6M-448%

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is TTRX's accrued liabilities & other?: TTRX (TTRX) reported accrued liabilities & other of $2.32M in Q1 2026.
What does accrued liabilities & other mean?: Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.